We are live on ! Find out more
CCC

Chelsea Counsel Company Portfolio holdings

AUM $225M
1-Year Est. Return 45.99%
This Fund
S&P 500
This Quarter Est. Return
+0.62%
1 Year Est. Return
+45.99%
3 Year Est. Return
+94.6%
5 Year Est. Return
+122.61%
10 Year Est. Return
+380.48%
AUM
$464M
AUM Growth
-$21.4M
Cap. Flow
-$21.7M
Cap. Flow %
-4.68%
Top 10 Hldgs %
38.18%
Holding
148
New
11
Increased
28
Reduced
44
Closed
7

Top Buys

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$1.49M
2
CMI icon
Cummins
CMI
+$599K
3
AAPL icon
Apple
AAPL
+$494K
4
GS icon
Goldman Sachs
GS
+$446K
5
VOD icon
Vodafone
VOD
+$406K

Top Sells

Rank Stock Value
1
BPL
Buckeye Partners, L.P.
BPL
+$5.47M
2
COST icon
Costco
COST
+$3.81M
3
HON icon
Honeywell
HON
+$3.54M
4
QCOM icon
Qualcomm
QCOM
+$3.54M
5
MMM icon
3M
MMM
+$3.3M

Sector Composition

Rank Sector Weight
1 Industrials 20.72%
2 Energy 16.85%
3 Communication Services 11.01%
4 Consumer Staples 10.77%
5 Healthcare 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CME icon
101
CME Group
CME
$93.7B
$336K 0.07%
+3,552
New +$329K
BRK.B icon
102
Berkshire Hathaway Class B
BRK.B
$1.12T
$325K 0.07%
2,249
FDX icon
103
FedEx
FDX
$76.5B
$317K 0.07%
+1,918
New +$333K
DOC icon
104
Healthpeak Properties
DOC
$14.2B
$312K 0.07%
7,922
WFC icon
105
Wells Fargo
WFC
$265B
$296K 0.06%
5,434
ECL icon
106
Ecolab
ECL
$79.8B
$286K 0.06%
2,500
MHG
107
DELISTED
Marine Harvest ASA
MHG
$285K 0.06%
25,050
TCOM icon
108
Trip.com Group
TCOM
$29.2B
$276K 0.06%
9,400
VRTX icon
109
Vertex Pharmaceuticals
VRTX
$135B
$271K 0.06%
2,300
SCE.PRE
110
DELISTED
Southern California Edison Company 4.78% Cum. Pfd.
SCE.PRE
$264K 0.06%
10,667
MO icon
111
Altria Group
MO
$108B
$260K 0.06%
5,195
SJM icon
112
J.M. Smucker
SJM
$12.6B
$258K 0.06%
2,227
DD
113
DELISTED
Du Pont De Nemours E I
DD
$258K 0.06%
3,801
PCYC
114
DELISTED
PHARMACYCLICS INC
PCYC
$256K 0.06%
1,000
-1,000
-50% -$193K
META icon
115
Meta Platforms (Facebook)
META
$1.56T
$247K 0.05%
3,000
-200
-6% -$15.7K
MCD icon
116
McDonald's
MCD
$193B
$233K 0.05%
2,394
FFIV icon
117
F5
FFIV
$23.5B
$230K 0.05%
2,000
BMY icon
118
Bristol-Myers Squibb
BMY
$130B
$226K 0.05%
3,504
-600
-15% -$37.6K
ELV icon
119
Elevance Health
ELV
$85.1B
$216K 0.05%
+1,400
New +$199K
TRN icon
120
Trinity Industries
TRN
$2.3B
$213K 0.05%
+8,334
New +$182K
AET
121
DELISTED
Aetna Inc
AET
$213K 0.05%
+2,000
New +$196K
BAX icon
122
Baxter International
BAX
$14.3B
$211K 0.05%
5,665
SBUX icon
123
Starbucks
SBUX
$122B
$208K 0.04%
+4,400
New +$198K
GTU
124
DELISTED
CENTRAL GOLD TR (CANADA)
GTU
$208K 0.04%
5,160
JPM icon
125
JPMorgan Chase
JPM
$960B
$206K 0.04%
3,401

Similar funds

Chelsea Counsel Company's Q1 2015 Portfolio in Review

As of Q1 2015, Chelsea Counsel Company held 148 positions worth $464M, down 4.4% from $486M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Chelsea Counsel Company withdrew a net $21.7M in Q1 2015, closing 7 positions and reducing 44 holdings. Its most notable exit was Bausch Health, an estimated $458K position sold in full.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 21% a quarter earlier, followed by Energy and Communication Services.

Against the trend, Chelsea Counsel Company opened a new position in Goldman Sachs worth $451K.

  • Chelsea Counsel Company's largest Q1 2015 buy was Goldman Sachs: 2,400 shares worth $451K.
  • Chelsea Counsel Company added most to EOG Resources in Q1 2015, an estimated $1.49M increase.
  • Chelsea Counsel Company's biggest Q1 2015 reduction was Buckeye Partners, L.P., cutting an estimated $5.47M.
  • Chelsea Counsel Company fully exited Bausch Health in Q1 2015, selling an estimated $458K.
  • Chelsea Counsel Company's ten largest holdings make up 38% of its $464M portfolio in Q1 2015.
  • Chelsea Counsel Company opened 11 new positions and closed 7 in Q1 2015.
  • Chelsea Counsel Company's portfolio value fell 4.4% quarter-over-quarter to $464M.

Based on Chelsea Counsel Company's 13F filing for Q1 2015, filed 29 May 2015.